Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology.
Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology.
复制标题
路易体病理患者阿尔茨海默病病理学临床相关性的性别差异。
DOI:
10.1002/mds.29044
复制
发表时间:
2022-07
影响因子:
8.6
通讯作者:
Litvan, Irene
中科院分区:
文献类型:
--
作者:
Bayram, Ece;Coughlin, David G.;Litvan, Irene
Lewy body (LB) dementias have limited clinical diagnostic accuracy due to frequent co-pathologies contributing to clinical heterogeneity. Although sex differences in clinical prevalence and frequency of pure LB pathology were shown, differences for clinicopathological correlations are less known. Determining sex differences for clinical associations of Alzheimer’s disease (AD) co-pathology in those with LB pathology Data was from National Alzheimer’s Coordinating Center for 223 women and 468 men with limbic or neocortical LB, separated into two groups as those with high likelihood and low/intermediate likelihood for LB clinical phenotype based on pathology. Clinical associations of sex and interaction of sex and pathology for the clinical phenotype were analyzed. More severe AD co-pathology was associated with worse cognitive decline and lower likelihood of LB disease clinical phenotype. Women with more severe AD co-pathology and tau had worse cognitive decline and higher likelihood of AD clinical phenotype than men. Men with more severe AD co-pathology had lower likelihood of LB clinical phenotype than women. Interaction of sex and pathology was more pronounced in those aged between 70 and 80. AD co-pathology lowers the likelihood of LB clinical phenotype for both women and men, however, men may be at higher risk of LB disease underdiagnosis and women at higher risk of dementia. The use of both LB and AD biomarkers, even when LB or AD pathology is not clinically expected, is necessary for the accurate clinical diagnosis of both LB diseases and AD.
登录
查看更多内容
影响因子:
4.2
作者:
Coughlin DG;Phillips JS;Roll E;Peterson C;Lobrovich R;Rascovsky K;Ungrady M;Wolk DA;Das S;Weintraub D;Lee EB;Trojanowski JQ;Shaw LM;Vaishnavi S;Siderowf A;Nasrallah IM;Irwin DJ;McMillan CT;Alzheimer’s Disease Neuroimaging Initiative
通讯作者:
Alzheimer’s Disease Neuroimaging Initiative
影响因子:
2.1
作者:
Besser L;Kukull W;Knopman DS;Chui H;Galasko D;Weintraub S;Jicha G;Carlsson C;Burns J;Quinn J;Sweet RA;Rascovsky K;Teylan M;Beekly D;Thomas G;Bollenbeck M;Monsell S;Mock C;Zhou XH;Thomas N;Robichaud E;Dean M;Hubbard J;Jacka M;Schwabe-Fry K;Wu J;Phelps C;Morris JC;Neuropsychology Work Group, Directors, and Clinical Core leaders of the National Institute on Aging-funded US Alzheimer’s Disease Centers
通讯作者:
Neuropsychology Work Group, Directors, and Clinical Core leaders of the National Institute on Aging-funded US Alzheimer’s Disease Centers
影响因子:
29
作者:
Hanseeuw, Bernard J.;Betensky, Rebecca A.;Johnson, Keith
通讯作者:
Johnson, Keith
影响因子:
3.2
作者:
Besser, Lilah M.;Kukull, Walter A.;Nelson, Peter T.
通讯作者:
Nelson, Peter T.
DOI:
10.1002/alz.12411
发表时间:
2022-04
期刊:
Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子:
--
作者:
Choudhury P;Graff-Radford J;Aakre JA;Wurtz L;Knopman DS;Graff-Radford NR;Kantarci K;Forsberg LK;Fields JA;Pedraza O;Chen Q;Miyagawa T;Day GS;Tipton P;Savica R;Botha H;Lachner C;Dredla B;Reichard RR;Petersen RC;Dickson DW;Boeve BF;Ferman TJ
通讯作者:
Ferman TJ